Insights

Investment Focus Advent Life Sciences specializes in early and mid-stage biotech and healthtech companies across the UK, Europe, and the US, presenting opportunities to partner with innovative firms engaged in cutting-edge drug discovery, biologics, med tech, and vaccines.

Strategic Partnerships The firm actively partners with growth-stage companies, exemplified by recent investments in Artax Biopharma, Moximed, and Proximie, indicating a potential interest in expanding its portfolio through future collaborations and funding opportunities.

Market Positioning As a leading trans-Atlantic venture investor with a proven track record of transforming breakthrough science into approved medicines, Advent Life Sciences is well-positioned to support startups and established companies seeking strategic funding and expertise.

Funding Capacity With a revenue range of 1 million to 10 million and active investments in high-value rounds such as $80 million in Proximie, there are opportunities to offer tailored financial products, co-investments, or consulting services to companies at various funding stages.

Leadership and Growth The recent hiring of Katrine Bosley as CEO, coupled with the firm’s focus on supporting innovative healthcare solutions, highlights its leadership’s commitment to growth and transformational investments, making it an attractive partner for companies seeking strategic scale-up support.

Advent Life Sciences LLP Tech Stack

Advent Life Sciences LLP uses 8 technology products and services including WordPress, Font Awesome, imagesLoaded, and more. Explore Advent Life Sciences LLP's tech stack below.

  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • imagesLoaded
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Elementor
    Page Builders
  • PHP
    Programming Languages
  • Animate.css
    UI Frameworks
  • Nginx
    Web Servers

Media & News

Advent Life Sciences LLP's Email Address Formats

Advent Life Sciences LLP uses at least 1 format(s):
Advent Life Sciences LLP Email FormatsExamplePercentage
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%

Frequently Asked Questions

What is Advent Life Sciences LLP's official website and social media links?

Minus sign iconPlus sign icon
Advent Life Sciences LLP's official website is adventls.com and has social profiles on LinkedIn.

What is Advent Life Sciences LLP's SIC code NAICS code?

Minus sign iconPlus sign icon
Advent Life Sciences LLP's SIC code is 6371 - Pension, Health, and Welfare Funds NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Advent Life Sciences LLP have currently?

Minus sign iconPlus sign icon
As of February 2026, Advent Life Sciences LLP has approximately 27 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Operating Partner: J. M.General Partner: S. J.General Partner: K. M.. Explore Advent Life Sciences LLP's employee directory with LeadIQ.

What industry does Advent Life Sciences LLP belong to?

Minus sign iconPlus sign icon
Advent Life Sciences LLP operates in the Venture Capital and Private Equity Principals industry.

What technology does Advent Life Sciences LLP use?

Minus sign iconPlus sign icon
Advent Life Sciences LLP's tech stack includes WordPressFont AwesomeimagesLoadedSlider RevolutionElementorPHPAnimate.cssNginx.

What is Advent Life Sciences LLP's email format?

Minus sign iconPlus sign icon
Advent Life Sciences LLP's email format typically follows the pattern of First.Last@adventls.com. Find more Advent Life Sciences LLP email formats with LeadIQ.

When was Advent Life Sciences LLP founded?

Minus sign iconPlus sign icon
Advent Life Sciences LLP was founded in 2005.

Advent Life Sciences LLP

Venture Capital and Private Equity PrincipalsEngland, United Kingdom11-50 Employees

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.

As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients.

The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.

Section iconCompany Overview

SIC Code
6371 - Pension, Health, and Welfare Funds
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences LLP's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences LLP's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.